NPPB and hydrops fetalis: The Comparison of Sacubitril–Valsartan versus Enalapril on Effect on N-terminal (NT) pro B-type-natriuretic peptide (BNP) (NT-proBNP) in Patients Stabilized from an Acute Heart Failure Episode (PIONEER-HF) trial has shown that this treatment is safe and more effective in reducing NT-proBNP levels than ACE inhibitors among patients hospitalized for acute decompensated HF, including ACE inhibitor/ARB-naïve patients [49].